PDF(Pubmed)
Abstract：
UNASSIGNED: Many therapies are available to treat low-risk superficial basal cell carcinoma (lr-sBCC), which may complicate the shared decision-making (SDM) process.
UNASSIGNED: To assess the SDM process of patients and physicians when deciding lr-sBCC therapy as well as the factors that may influence the SDM process.
UNASSIGNED: A prospective, multicenter cohort study was conducted over 18 months, from October 2018 to April 2020, in 3 tertiary university hospitals and 1 private hospital.
UNASSIGNED: This study included 107 patients. There was a weak positive correlation between Shared Decision-Making Questionnaire-Patient version (SDM-Q-9) and Shared Decision-Making Questionnaire-Physician version (SDM-Q-Doc) (Spearman\'s correlation coefficient [rs] [105] = 0.21; P = .03). Most patients (71%) chose a nonsurgical treatment after the SDM process. Patients with higher satisfaction with the SDM had lower decisional conflict and decisional regret (P < .001). Patients aged >80 years had higher rates of significant decisional conflict. When evaluating treatment decisions, the highest median score for decisional conflict (22, IQR [16]; P = .01) was observed among patients who chose a surgical excision.
UNASSIGNED: Patients may have self-selected to participate.
UNASSIGNED: This study suggests that some patients may prefer less invasive therapies for lr-sBCC. The SDM process may reduce decisional conflict and decisional regret.
UNASSIGNED: To assess the SDM process of patients and physicians when deciding lr-sBCC therapy as well as the factors that may influence the SDM process.
UNASSIGNED: A prospective, multicenter cohort study was conducted over 18 months, from October 2018 to April 2020, in 3 tertiary university hospitals and 1 private hospital.
UNASSIGNED: This study included 107 patients. There was a weak positive correlation between Shared Decision-Making Questionnaire-Patient version (SDM-Q-9) and Shared Decision-Making Questionnaire-Physician version (SDM-Q-Doc) (Spearman\'s correlation coefficient [rs] [105] = 0.21; P = .03). Most patients (71%) chose a nonsurgical treatment after the SDM process. Patients with higher satisfaction with the SDM had lower decisional conflict and decisional regret (P < .001). Patients aged >80 years had higher rates of significant decisional conflict. When evaluating treatment decisions, the highest median score for decisional conflict (22, IQR [16]; P = .01) was observed among patients who chose a surgical excision.
UNASSIGNED: Patients may have self-selected to participate.
UNASSIGNED: This study suggests that some patients may prefer less invasive therapies for lr-sBCC. The SDM process may reduce decisional conflict and decisional regret.
摘要：
■许多疗法可用于治疗低风险浅表性基底细胞癌（lr-sBCC），这可能会使共享决策(SDM)过程复杂化。
■评估患者和医师在决定lr-sBCC治疗时的SDM过程以及可能影响SDM过程的因素。
■预期，多中心队列研究进行了18个月，从2018年10月到2020年4月，在3所三级大学医院和1所私立医院。
■这项研究包括107名患者。共享决策问卷-患者版本（SDM-Q-9）和共享决策问卷-医师版本（SDM-Q-Doc）之间存在弱正相关（Spearman相关系数[rs][105]=0.21；P=.03）。大多数患者（71％）在SDM过程后选择了非手术治疗。对SDM满意度较高的患者具有较低的决策冲突和决策后悔(P<.001)。年龄>80岁的患者发生重大决策冲突的比率更高。在评估治疗决定时，在选择手术切除的患者中,决策冲突的中位数得分最高(22,IQR[16];P=.01).
■患者可以自行选择参加。
■这项研究表明，一些患者可能更喜欢对lr-sBCC进行侵入性较小的治疗。SDM过程可以减少决策冲突和决策遗憾。
■评估患者和医师在决定lr-sBCC治疗时的SDM过程以及可能影响SDM过程的因素。
■预期，多中心队列研究进行了18个月，从2018年10月到2020年4月，在3所三级大学医院和1所私立医院。
■这项研究包括107名患者。共享决策问卷-患者版本（SDM-Q-9）和共享决策问卷-医师版本（SDM-Q-Doc）之间存在弱正相关（Spearman相关系数[rs][105]=0.21；P=.03）。大多数患者（71％）在SDM过程后选择了非手术治疗。对SDM满意度较高的患者具有较低的决策冲突和决策后悔(P<.001)。年龄>80岁的患者发生重大决策冲突的比率更高。在评估治疗决定时，在选择手术切除的患者中,决策冲突的中位数得分最高(22,IQR[16];P=.01).
■患者可以自行选择参加。
■这项研究表明，一些患者可能更喜欢对lr-sBCC进行侵入性较小的治疗。SDM过程可以减少决策冲突和决策遗憾。
